Contemporary Treatment of Heart Failure.
Card Electrophysiol Clin
; 11(1): 21-37, 2019 03.
Article
en En
| MEDLINE
| ID: mdl-30717850
Heart failure (HF) affects 2.4% of the adult population in the United States and is associated with high health care costs. Medical and device therapy delay disease progression and improve survival in HF with reduced ejection fraction. Stage D HF is characterized by significant functional limitation, frequent HF hospitalization for decompensation, intolerance of medical therapy, use of inotropes, and high diuretic requirement. Advanced therapies with left ventricular assist devices and cardiac transplantation reduce mortality and improve quality of life, and early referral to specialized centers is imperative for patient selection and success with these therapies.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Insuficiencia Cardíaca
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
En
Revista:
Card Electrophysiol Clin
Año:
2019
Tipo del documento:
Article
Pais de publicación:
Estados Unidos